Transplenic and transtumoral in vivo immunostimulation: Effect on cellular immunity parameters

Hepato-Gastroenterology

Volumn 46, Issue 26, 1999, Pages 799-803

  Boura, P ^a,c   Kountouras, J ^a   Lygidakis, N J ^b   Safioleas, M ^b   Aphinives, P ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ATHENS MEDICAL CENTER   (Greece)

^c NONE   (Greece)

Author keywords

Hepatocellular carcinoma; Immunological response; Interleukin 2; Locoregional treatment; Malignant metastatic disease; Pancreatic cancer

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE;

ADULT; AGED; ARTICLE; ASCITES; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CHILL; CLINICAL ARTICLE; EDEMA; EMULSION; FEMALE; FEVER; HUMAN; HUMAN CELL; HYPOTENSION; IMMUNOPOTENTIATION; IMMUNOSTIMULATION; INOPERABLE CANCER; INTRATUMORAL DRUG ADMINISTRATION; LIVER TUMOR; MALE; MYALGIA; NAUSEA; NEUTROPENIA; PANCREAS TUMOR; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIA; TUMOR IMMUNOLOGY; VOMITING;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNITY, CELLULAR; INJECTIONS, INTRALESIONAL; INTERFERON TYPE II; INTERLEUKIN-2; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SPLEEN; T-LYMPHOCYTES;

EID: 0032935468     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 1 Lygidakis NJ, Konstantinou T, Pothoulakis J: Pre-and post-operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative. Anticancer Res 1994; pp. 1351-1356.
2. 2 Lygidakis NJ, Savanis G, Pothoulakis J, Kapetanakis A: Transarterial locoregional immunostimulation and chemotherapy in patients with unresectable secondary liver tumors. Anticancer Res 1994; pp. 643-646.
3. 3 Lin G: Hepatic arterial embolization with Lipiodol: experimental and clinical applications. Proceedings of the First National Liver Cancer Conference. Shangai, China, Nov. 24-26 1988; p. 130.
4. 4 Lygidakis NJ, Stringalis K, Kokinis K, Lyberopoulos K, Raptis S: Locoregional immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomised study. Hepato-Gastroenterol 1996; 43:212-220.
5. 5 Lygidakis NJ, Savanis G, et al: A new look in the management of unresectable hepatocellular carcinoma. Hepato-Gastroenterol 1992; 39:577-583.
6. 6 Lygidakis NJ, Savanis G, et al: Technical consideration and results of a "new" method of reconstruction of alimentary continuity after duodenopancreatectomy. Hepato-Gastroenterol 1993; 40:448-451.
7. 7 Lygidakis NJ: Reconstruction of alimentary continuity after subtotal duodenopancreatectomy. Hepato-Gastroenterol 1996; 43:971-979.
8. 8 Lygidakis NJ: Regional vascular resection for pancreatic head carcinoma. Hepato-Gastroenterol 1996; 43:1327-1333.
9. 9 Tanaka T, Yasuda H, Amano H, Yoshida M, Uchida T: Simultaneous hepatic resection with pancreatoduodenectomy for metastatic pancreatic head carcinoma: Does it improve survival? Hepato-Gastroenterol 1997; 44:567-573.
10. 10 Lygidakis NJ, Dedemadi G, Spentzouris N, Theodoropoulou M: Unresectable pancreatic cancer: Is a multi-modality approach a promising therapeutical alternative? Hepato-Gastroenterol 1991; 44:1222-1228.
11. 11 Lygidakis NJ, Tsiliakos S, Talaat A, Matsakis G, Tepetes K: Multidisciplinary management of hepatocellular carcinoma. Hepato-Gastroenterol 1997; 44:268-273.
12. 12 Lucey RD, Clerici M, Eisenstein E, Fleisher AT, Shearer MG: Assessment of lymphocyte and monocyte function. Principles and practice. In: Rich RR (Ed.). Mosby Publ. St. Louis, Missouri, 1996; p. 231.
13. 13 Ioannidis CG, Grimm EA: Tumor immunity. Principles and practice. In: Rich RR (Ed.). Mosby Publ. St. Louis, Missouri, 1996; pp. 333-349.
14. 14 Pegram M, Mitsuyasu RT: Immune modulation: Interferons and Interleukins. In: Rich RR (Ed.). Mosby Publ. St. Louis, Missouri, 1996; pp. 2030-2045.
15. 15 Kountouras J, Boura P, Karolides A, Zaharioudaki E, Tsapas G: Recombinant a2 Interferon (α-IFN) with chemohormonal therapy in patients with hepatocellular carcinoma (HCC). Hepato-Gastroenterol 1995; 42:31-36.